【Lotus Pharmaceutical】Announcement of the Board of Directors' Resolution to Approve the 2026 First Quarter Financial Report
Lotus Pharmaceutical's Board of Directors has approved the financial report for the first quarter of 2026. The report shows revenue of NT$8,644,409 thousand, net profit of NT$567,201 thousand, and EPS of NT$2.18.
📋 Article Processing Timeline
- 📰 Published: May 11, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 19:09 (11h 9m after Collected)
1. Date of submission to the board of directors or resolution by the board of directors: 2026/05/11
2. Date of approval by the audit committee: 2026/05/08
3. Reporting period for financial report or self-compiled financial information
Start and end dates (YYYY/MM/DD~YYYY/MM/DD): 2026/01/01 ~ 2026/03/31
4. Cumulative operating revenue from January 1 to the end of this period (in thousands of NTD): 8,644,409
5. Cumulative operating gross profit (loss) from January 1 to the end of this period (in thousands of NTD): 4,385,622
6. Cumulative operating income (loss) from January 1 to the end of this period (in thousands of NTD): 1,959,197
7. Cumulative pre-tax net profit (loss) from January 1 to the end of this period (in thousands of NTD): 725,899
8. Cumulative net profit (loss) for this period from January 1 to the end of this period (in thousands of NTD): 567,201
9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of this period (in thousands of NTD): 567,201
10. Cumulative basic earnings per share (loss) from January 1 to the end of this period (in NTD): 2.18
11. Total assets at the end of the period (in thousands of NTD): 107,533,585
12. Total liabilities at the end of the period (in thousands of NTD): 83,501,410
13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 24,032,175
14. Other matters to be specified: None
Keywords: Material Information
2. Date of approval by the audit committee: 2026/05/08
3. Reporting period for financial report or self-compiled financial information
Start and end dates (YYYY/MM/DD~YYYY/MM/DD): 2026/01/01 ~ 2026/03/31
4. Cumulative operating revenue from January 1 to the end of this period (in thousands of NTD): 8,644,409
5. Cumulative operating gross profit (loss) from January 1 to the end of this period (in thousands of NTD): 4,385,622
6. Cumulative operating income (loss) from January 1 to the end of this period (in thousands of NTD): 1,959,197
7. Cumulative pre-tax net profit (loss) from January 1 to the end of this period (in thousands of NTD): 725,899
8. Cumulative net profit (loss) for this period from January 1 to the end of this period (in thousands of NTD): 567,201
9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of this period (in thousands of NTD): 567,201
10. Cumulative basic earnings per share (loss) from January 1 to the end of this period (in NTD): 2.18
11. Total assets at the end of the period (in thousands of NTD): 107,533,585
12. Total liabilities at the end of the period (in thousands of NTD): 83,501,410
13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 24,032,175
14. Other matters to be specified: None
Keywords: Material Information